Nutra Pharma Announces Nyloxin Rx, A Prescription Analgesic For The Treatment Of Severe (Stage 3) Chronic Pain
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain. Nyloxin Rx is a prescription pain reliever produced by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm.
Related Posts
Tags: analgesic, chronic, nutra, nyloxin, pain, pharma, prescription, severe, stage, treatment
This entry was posted on Sunday, October 11th, 2009 at 9:10 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



